Extracellular matrix remodeling in tumor progression and immune escape: from mechanisms to treatments
Z Yuan, Y Li, S Zhang, X Wang, H Dou, X Yu, Z Zhang… - Molecular cancer, 2023 - Springer
The malignant tumor is a multi-etiological, systemic and complex disease characterized by
uncontrolled cell proliferation and distant metastasis. Anticancer treatments including …
uncontrolled cell proliferation and distant metastasis. Anticancer treatments including …
Matrix metalloproteinases: from molecular mechanisms to physiology, pathophysiology, and pharmacology
LGN de Almeida, H Thode, Y Eslambolchi… - Pharmacological …, 2022 - ASPET
The first matrix metalloproteinase (MMP) was discovered in 1962 from the tail of a tadpole by
its ability to degrade collagen. As their name suggests, matrix metalloproteinases are …
its ability to degrade collagen. As their name suggests, matrix metalloproteinases are …
The extracellular matrix as hallmark of cancer and metastasis: From biomechanics to therapeutic targets
JJF Sleeboom, GS van Tienderen… - Science translational …, 2024 - science.org
The extracellular matrix (ECM) is essential for cell support during homeostasis and plays a
critical role in cancer. Although research often concentrates on the tumor's cellular aspect …
critical role in cancer. Although research often concentrates on the tumor's cellular aspect …
Neutrophils in physiology and pathology
A Aroca-Crevillén, T Vicanolo, S Ovadia… - Annual Review of …, 2024 - annualreviews.org
Infections, cardiovascular disease, and cancer are major causes of disease and death
worldwide. Neutrophils are inescapably associated with each of these health concerns, by …
worldwide. Neutrophils are inescapably associated with each of these health concerns, by …
[HTML][HTML] Mesenchymal stem cell-derived exosome: A tumor regulator and carrier for targeted tumor therapy
F Zhang, J Guo, Z Zhang, Y Qian, G Wang, M Duan… - Cancer letters, 2022 - Elsevier
Mesenchymal stem cells (MSCs) are multipotent stromal cells that have the ability to
differentiate into multiple cell types. Several studies have shown that exosomes secreted by …
differentiate into multiple cell types. Several studies have shown that exosomes secreted by …
Integrated multi-omics investigations of metalloproteinases in colon cancer: Focus on MMP2 and MMP9
M Buttacavoli, G Di Cara, E Roz… - International journal of …, 2021 - mdpi.com
Colorectal cancer (CRC) develops by genetic and epigenetic alterations. However, the
molecular mechanisms underlying metastatic dissemination remain unclear and could …
molecular mechanisms underlying metastatic dissemination remain unclear and could …
The functional role of extracellular matrix proteins in cancer
NV Popova, M Jücker - Cancers, 2022 - mdpi.com
Simple Summary Extracellular matrix is a three-dimensional network of macromolecules that
provide structural and biochemical support to surrounding cells. Extracellular matrix plays a …
provide structural and biochemical support to surrounding cells. Extracellular matrix plays a …
Harnessing normal and engineered mesenchymal stem cells derived exosomes for cancer therapy: opportunity and challenges
There remains a vital necessity for new therapeutic approaches to combat metastatic
cancers, which cause globally over 8 million deaths per year. Mesenchymal stem cells …
cancers, which cause globally over 8 million deaths per year. Mesenchymal stem cells …
Recreating the extracellular matrix: novel 3D cell culture platforms in cancer research
Cancer initiation and progression heavily rely on microenvironmental cues derived from
various components of the niche including the extracellular matrix (ECM). ECM is a complex …
various components of the niche including the extracellular matrix (ECM). ECM is a complex …
Cancer-associated fibroblast-derived gene signatures predict radiotherapeutic survival in prostate cancer patients
R Zhang, F Liu - Journal of Translational Medicine, 2022 - Springer
Abstract Background Cancer-associated fibroblasts (CAFs) play multiple roles in regulating
tumor metastasis and treatment response. Current clinical indicators are insufficient to …
tumor metastasis and treatment response. Current clinical indicators are insufficient to …